)
The Oncology Institute (TOI) investor relations material
The Oncology Institute Q3 2025 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Executive summary
Q3 2025 revenue reached $136.6 million, up 36.7% year-over-year, with record performance in Pharmacy/Dispensary and strong organic growth in Florida and Oregon.
Adjusted EBITDA improved to -$3.5 million from -$8.2 million in Q3 2024, with the first profitable month in September and operational efficiencies driving improvement.
Net loss for Q3 2025 was $16.5 million, compared to $16.1 million in Q3 2024; net loss for the nine months ended September 30, 2025 was $53.1 million.
Expanded network in Florida with new MSO providers, opened a new pharmacy location, and appointed a new Chief Administrative Officer to oversee business operations and AI strategy.
Operates 80 clinics in 22 markets, serving 1.9 million lives under value-based contracts.
Financial highlights
Pharmacy/Dispensary revenue grew 57.4% to $75.9 million; patient services revenue rose 21% to $60.2 million.
Gross profit was $18.9 million (13.9% margin); normalized gross profit would have been $20.7 million (15.2% margin).
Net loss per share for Q3 2025 was $(0.14), compared to $(0.18) in Q3 2024.
Cash and cash equivalents were $27.7 million as of September 30, 2025; ended Q3 with $86 million in convertible debt maturing in 2027.
Cash flow from operations was -$27.8 million for the nine months ended September 30, 2025, a 9.5% improvement year-over-year.
Outlook and guidance
Raised full-year 2025 revenue guidance to $495–$505 million (from $460–$480 million).
Adjusted EBITDA guidance improved to a loss of -$13 million to -$11 million, with Q4 adjusted EBITDA expected between break-even and +$2 million.
Free Cash Flow guidance for 2025 is $(12)–$(21) million; expect free cash flow positivity by mid-2026.
Management expects sufficient liquidity to fund operations for at least one year from the reporting date.
Anticipate continued 20%+ top-line growth and stable gross margin and SG&A as a percent of revenue in 2026.
Next The Oncology Institute earnings date
Next The Oncology Institute earnings date
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
)
)
)
Frequently asked questions
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Explore our global coverage